Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 9.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,634 shares of the biotechnology company’s stock after purchasing an additional 2,390 shares during the quarter. […]
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Short Interest Down 6 9% in April theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) rose 4.6% during mid-day trading on Monday . The stock traded as high as $5.25 and last traded at $5.24. Approximately 959,196 shares changed hands during mid-day trading, a decline of 60% from the average daily volume of 2,388,016 shares. The stock had previously closed at […]
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) – Equities research analysts at HC Wainwright lifted their Q3 2023 earnings per share estimates for shares of Aurinia Pharmaceuticals in a research report issued on Monday, August 7th. HC Wainwright analyst E. Arce now anticipates that the biotechnology company will post earnings per share of ($0.14) […]
03.08.2023 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the three and six months ended June 30, 2023. Amounts are expressed in U.S. dollars. Total net revenue was $41.5 million for the three months .